RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.7836
-0.0415 (-5.03%)
Apr 13, 2026, 12:47 PM EDT - Market open

RedHill Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
484713136310
Market Cap Growth
14.47%-82.78%255.83%-90.38%-56.19%44.92%
Enterprise Value
1.573.441.41-0.46184.12365.66
Last Close Price
0.786.2136.50140.302580.008080.00
PE Ratio
--0.37-0.12-1.233.85
PS Ratio
0.441.007.120.211.594.82
PB Ratio
--1.7122.49-0.2715.3222.38
P/TBV Ratio
-0.28-1.634.57-0.1813.5321.23
P/FCF Ratio
--0.85-1.30-0.44-2.09-6.33
P/OCF Ratio
--0.86-1.30-0.45-2.09-6.39
EV/Sales Ratio
0.160.426.34-0.012.155.68
EV/EBITDA Ratio
-0.22-3.89-0.011.85-6.66
EV/EBIT Ratio
-0.23-3.28-0.012.27-5.74
EV/FCF Ratio
--0.36-1.160.02-2.83-7.46
Debt / Equity Ratio
-0.000.22-0.139.716.14
Debt / EBITDA Ratio
0.020.02-0.112.410.88-1.58
Debt / FCF Ratio
-0.03-0.04-0.03-4.18-1.35-1.77
Net Debt / Equity Ratio
0.600.91-2.12-2.125.614.12
Net Debt / EBITDA Ratio
-0.24-0.280.412.010.50-1.04
Net Debt / FCF Ratio
0.320.450.12-3.49-0.76-1.17
Asset Turnover
0.520.390.070.360.470.51
Inventory Turnover
1.000.790.452.584.638.78
Quick Ratio
0.370.320.410.280.860.80
Current Ratio
0.560.540.810.441.090.96
Return on Equity (ROE)
-204.79%-632.59%103.24%-362.65%859.70%-138.62%
Return on Assets (ROA)
57.90%71.13%-13.89%25.20%44.90%-50.08%
Return on Invested Capital (ROIC)
337.21%246.16%-20.00%37.69%71.98%-96.11%
Return on Capital Employed (ROCE)
-260.58%-2618.82%71.13%140.16%78.50%-74.71%
Earnings Yield
-220.76%0.00%273.97%-855.31%-81.40%25.99%
FCF Yield
-194.64%-117.07%-77.01%-224.72%-47.94%-15.79%
Buyback Yield / Dilution
-97.35%-375.56%-320.45%-32.46%-27.73%-22.68%
Total Shareholder Return
-97.35%-375.56%-320.45%-32.46%-27.73%-22.68%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q